Rafex Gold Corp.
Rafex Gold Corp., a development stage company, focuses on operating in the natural resource industry in Russia. The company intends to acquire a gold mine in the North Baikal region of Buryatia that covers an area of approximately 20 square kilometers. It also engages in the forestry operations in Buryatia for round timber and sawn wood. The company was formerly known as Sakha Enterprises Corpora… Read more
Rafex Gold Corp. (RAFX) - Net Assets
Latest net assets as of March 2025: $750.61K USD
Based on the latest financial reports, Rafex Gold Corp. (RAFX) has net assets worth $750.61K USD as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.02 Million) and total liabilities ($267.38K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $750.61K |
| % of Total Assets | 73.73% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Rafex Gold Corp. - Net Assets Trend (2022–2024)
This chart illustrates how Rafex Gold Corp.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Rafex Gold Corp. (2022–2024)
The table below shows the annual net assets of Rafex Gold Corp. from 2022 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $764.11K | -16.63% |
| 2023-12-31 | $916.50K | +37340.76% |
| 2022-12-31 | $-2.46K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Rafex Gold Corp.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 24960200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $27.29K | 3.57% |
| Other Comprehensive Income | $-83.06K | -10.87% |
| Other Components | $2.39 Million | 313.03% |
| Total Equity | $764.11K | 100.00% |
Rafex Gold Corp. Competitors by Market Cap
The table below lists competitors of Rafex Gold Corp. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
THC Farmaceuticals Inc
PINK:CBDG
|
$121.95 |
|
National Health Scan
PINK:GEGR
|
$122.33 |
|
Amtex Limited
KAR:AMTEX
|
$122.47 |
|
Surya Oil & Gas Corp.
NASDAQ:SURY
|
$123.21 |
|
Bank Maybank Indonesia Tbk PT
JK:BNII
|
$121.78 |
|
Zhuding International Ltd
PINK:ZHUD
|
$121.66 |
|
SHENGLI OIL & GAS
MU:GSG
|
$121.21 |
|
Raslag Corp.
PSE:ASLAG
|
$121.10 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Rafex Gold Corp.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 916,495 to 764,105, a change of -152,390 (-16.6%).
- Net loss of 89,793 reduced equity.
- Other comprehensive income decreased equity by 84,087.
- Other factors increased equity by 21,490.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-89.79K | -11.75% |
| Other Comprehensive Income | $-84.09K | -11.0% |
| Other Changes | $21.49K | +2.81% |
| Total Change | $- | -16.63% |
Book Value vs Market Value Analysis
This analysis compares Rafex Gold Corp.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.45x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $0.00 | $0.01 | x |
| 2020-12-31 | $0.00 | $0.01 | x |
| 2021-12-31 | $-0.02 | $0.01 | x |
| 2022-12-31 | $0.00 | $0.01 | x |
| 2023-12-31 | $0.04 | $0.01 | x |
| 2024-12-31 | $0.03 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Rafex Gold Corp. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -11.75%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.32x
- Recent ROE (-11.75%) is below the historical average (-3.72%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.03K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.36K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-8.76K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-50.94K |
| 2023 | -10.59% | 0.00% | 0.00x | 1.04x | $-188.68K |
| 2024 | -11.75% | 0.00% | 0.00x | 1.32x | $-166.20K |
Industry Comparison
This section compares Rafex Gold Corp.'s net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Rafex Gold Corp. (RAFX) | $750.61K | 0.00% | 0.36x | $121.79 |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |